title: Decision making in liver transplantation--limited application of the liver donor risk index.
abstract: The liver donor risk index (LDRI), originally developed in 2006 by Feng et al. and since modified, is a method of evaluating liver grafts from deceased donors through the determination of the relative risk of graft failure after transplantation. Online and paper surveys about attitudes and practices regarding decision making in liver transplantation and the role of the LDRI were sent to liver transplant physicians. One hundred forty-seven of 401 eligible respondents (37%) returned partial or complete surveys. The majority of the respondents were male (116/134 or 87%) and practiced in academic medical centers (128/138 or 93%). Transplant coordinators initially contacted the candidate with an offer in 81% of the programs. Eighty-eight of 143 respondents (62%) reported that they were very familiar with the LDRI, but the vast majority (114/137 or 83%) rarely or never discussed the concept of the LDRI with their patients. A majority of the respondents (96/132 or 73%) believed that the LDRI does not adequately describe a liver's relative risk of graft failure and that there are factors making the LDRI potentially misleading (122/138 or 88%). Nevertheless, 60 of 130 respondents (46%) believed that the LDRI would increase/improve shared decision making. The LDRI has not been widely adopted because of concerns that (1) it does not accurately reflect posttransplant survival, (2) it excludes relevant donor and recipient factors, and (3) it is too complicated for candidates to grasp. There is a need to improve it or to develop other decision-making tools to help promote shared decision making. There is also great diversity in how liver offers are made to ambulatory candidates and in how transplant programs address a candidate's refusal. Research is needed to determine evidence-based best practice.
authors.affiliation: Pritzker School of Medicine, University of Chicago University, Chicago, IL.
authors.forename: Leslie
authors.initials: L
authors.lastname: Mataya
authors.forename: Andrew
authors.initials: A
authors.lastname: Aronsohn
authors.forename: J Richard
authors.initials: JR
authors.lastname: Thistlethwaite
authors.forename: Lainie
authors.initials: L
authors.lastname: Friedman Ross
mesh_terms: D000046:Academic Medical Centers; D000328:Adult; D003657:Decision Making; D058625:End Stage Liver Disease / Q000628:therapy*; D005260:Female; D006085:Graft Survival; D006801:Humans; D008099:Liver / Q000473:pathology; D016031:Liver Transplantation; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D010820:Physicians; D012307:Risk Factors; D011795:Surveys and Questionnaires; D009927:Tissue and Organ Procurement / Q000379:methods*; D016896:Treatment Outcome